Brain and central nervous system tumors Trials in Bloomington, United States
Conditions / Brain and central nervous system tumors / Bloomington, United States
Brain and central nervous system tumors has been the subject of sustained clinical investigation across multiple research sites.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01004887 | Study of Tissue and Blood Samples From Patients With High-Grade Glioma | COMPLETED | — |
| NCT00869401 | Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | COMPLETED | PHASE1/PHASE2 |
| NCT00304031 | Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma | COMPLETED | PHASE3 |
| NCT00006386 | Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme | COMPLETED | PHASE2 |
| NCT00003417 | Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme | COMPLETED | PHASE1/PHASE2 |
| NCT00978458 | Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00004259 | Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas | COMPLETED | PHASE3 |
| NCT00887146 | Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00006388 | Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme | COMPLETED | PHASE2 |
| NCT00553150 | Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma | COMPLETED | PHASE1/PHASE2 |